Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Mekori

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Treatment Reports|March 1, 1985
Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy)E Robinson, N Haim, R Segal, et al.
Acta Haematologica|January 1, 1978
Multiple lymphocyte transformation tests by phytohemagglutinin in healthy individuals: transient episodes of decreased lymphocyte blastogenesisA Bartal, T Mekori, R Haasz, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|February 1, 1979
Adjuvant therapy in colorectal cancer. (A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with the methanol extraction residue of BCG, MER)E Robinson, A Bartal, Y Cohen, et al.
Cancer|September 1, 1977
Treatment of lung cancer by radiotherapy, chemotherapy, and methanol extraction residue of BCG (MER): clinical and immunological studiesE Robinson, A Bartal, Y Cohen, et al.
International Journal of Immunopharmacology|January 1, 1983
Oral administration of the methanol extraction residue of BCG (MER/BCG): a phase I study in non-oat cell lung cancer patientsA H Bartal, D Mordohovich, C Lichtig, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Combined adjuvant therapy of radically operated colorectal cancer patients. (chemotherapy, radiotherapy, and MER-BCG)E Robinson, A Bartal, Y Cohen, et al.
Journal of Biological Response Modifiers|January 1, 1984
Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patientsN Haim, A Meidav, B Samuelly, et al.
Cancer|May 1, 1999
Lymphocyte subpopulations in patients with multiple primary tumorsE Robinson, R Segal, L Struminger, et al.
International Journal of Cancer|December 2, 1991
A novel 21-kDa protein as a serum marker for benign and malignant urogenital tumors: preliminary communicationC Shalitin, R Epelbaum, C Valansi, et al.
International Journal of Oncology|May 18, 2011
Enzyme-linked-immunosorbent-assay for the detection of a novel 21-kda protein associated with the clinical course of patients with urogenital tumorsC Shalitin, R Epelbaum, B Moskovitz, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Treatment Reports|March 1, 1985
Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy)E Robinson, N Haim, R Segal, et al.
Acta Haematologica|January 1, 1978
Multiple lymphocyte transformation tests by phytohemagglutinin in healthy individuals: transient episodes of decreased lymphocyte blastogenesisA Bartal, T Mekori, R Haasz, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|February 1, 1979
Adjuvant therapy in colorectal cancer. (A randomized trial comparing radio-chemotherapy and radio-chemotherapy combined with the methanol extraction residue of BCG, MER)E Robinson, A Bartal, Y Cohen, et al.
Cancer|September 1, 1977
Treatment of lung cancer by radiotherapy, chemotherapy, and methanol extraction residue of BCG (MER): clinical and immunological studiesE Robinson, A Bartal, Y Cohen, et al.
International Journal of Immunopharmacology|January 1, 1983
Oral administration of the methanol extraction residue of BCG (MER/BCG): a phase I study in non-oat cell lung cancer patientsA H Bartal, D Mordohovich, C Lichtig, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Combined adjuvant therapy of radically operated colorectal cancer patients. (chemotherapy, radiotherapy, and MER-BCG)E Robinson, A Bartal, Y Cohen, et al.
Journal of Biological Response Modifiers|January 1, 1984
Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patientsN Haim, A Meidav, B Samuelly, et al.
Cancer|May 1, 1999
Lymphocyte subpopulations in patients with multiple primary tumorsE Robinson, R Segal, L Struminger, et al.
International Journal of Cancer|December 2, 1991
A novel 21-kDa protein as a serum marker for benign and malignant urogenital tumors: preliminary communicationC Shalitin, R Epelbaum, C Valansi, et al.
International Journal of Oncology|May 18, 2011
Enzyme-linked-immunosorbent-assay for the detection of a novel 21-kda protein associated with the clinical course of patients with urogenital tumorsC Shalitin, R Epelbaum, B Moskovitz, et al.
Pageof 3